Use of cannabidiol in the treatment of epilepsy
OwnerVolker KNAPPERTZinventor
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of seizures in patients aged about 1-2 years old. In particular the CBD appears particularly effective in reducing seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; Aicardi syndrome; CDKL5 and Dun15q.
Claims28
A method of treating seizures in a patient in need thereof, comprising administering to the patient a cannabidiol (CBD) drug substance, wherein the CBD drug substance has a purity of at least 95% (w/w) CBD, wherein the patient is about 1-2 years of age, and wherein the CBD is administered at a dose ranging from about 5 mg/kg/day to about 50 mg/kg/day.
Dependencies are inferred from the claim text.